Shang-Zhen Zhou

Title: The Innovations of Shang-Zhen Zhou

Introduction

Shang-Zhen Zhou is a notable inventor based in Alameda, CA. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant adenovirus vectors and methods for producing purified AAV virions. With a total of 2 patents, his work has advanced the understanding and application of gene therapy technologies.

Latest Patents

Shang-Zhen Zhou's latest patents include innovations in AAV vectors. The first patent focuses on a recombinant adenovirus vector that comprises two inverted terminal repeats (ITRs), each containing a D-sequence with specific nucleotide characteristics. The second patent presents a method for producing purified replication-defective recombinant AAV virions. This method involves introducing an AAV vector, an AAV helper construct, and an adenoplasmid accessory construct into a suitable host cell, followed by a series of purification steps to recover the rAAV virions.

Career Highlights

Throughout his career, Shang-Zhen Zhou has worked with various organizations, including Chiron Corporation. His expertise in biotechnology has allowed him to contribute to significant advancements in the field, particularly in gene therapy applications.

Collaborations

Shang-Zhen Zhou has collaborated with notable colleagues such as Jaime A Escobedo and Varavani J Dwarki. These collaborations have further enriched his research and development efforts in biotechnology.

Conclusion

Shang-Zhen Zhou's innovative work in the field of biotechnology, particularly in AAV vectors and virion production methods, showcases his significant contributions to the advancement of gene therapy technologies. His patents reflect a commitment to improving therapeutic approaches and enhancing the understanding of viral vectors.